Pregled bibliografske jedinice broj: 175977
Stereoselective analysis of 2-hydroxysebacic acid in urine of patients with Zellweger syndrome and of premature infants fed with medium chain tryglycerides.
Stereoselective analysis of 2-hydroxysebacic acid in urine of patients with Zellweger syndrome and of premature infants fed with medium chain tryglycerides. // Journal of inherited metabolic disease, 26 (2003), 6; 583-592 (podatak o recenziji nije dostupan, znanstveni rad, znanstveni)
CROSBI ID: 175977 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Stereoselective analysis of 2-hydroxysebacic acid in urine of patients with Zellweger syndrome and of premature infants fed with medium chain tryglycerides.
Autori
Muth, A. ; Mosandl, A. ; Wanders, R.J. ; Nowaczyk, M.J. ; Barić, Ivo ; Bohles, H. ; Sewell, A.C.
Izvornik
Journal of inherited metabolic disease (0141-8955) 26
(2003), 6;
583-592
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, znanstveni rad, znanstveni
Ključne riječi
2-hydroxysebacic acid; Zellweger syndrome; premature infant
Sažetak
The chiral metabolite 2-hydroxysebacic acid (2-HS) is considered to be an important diagnostic marker for peroxisomal disorders. The pathway of formation of 2-HS, excreted in increased amounts in patients with peroxisomal diseases, is not absolutely clear. Moreover, there is no information about the enantiomeric distribution of 2-HS in human urine. Here, we describe the stereodifferentiation of 2-HS in urine samples of nine patients with Zellweger syndrome (ZS), and for the first time in urine samples of premature infants fed a medium-chain triglyceride (MCT)-containing diet. Using enantioselective multidimensional gas chromatography-mass spectrometry, an increased excretion of 2R-HS was observed in all investigated ZS patients. 2-HS was also present in urine samples of premature infants fed MCT. Analogously to the ZS patients, a dominant 2R-HS excretion in the urine samples of the premature infants was identified. The formation of 2-HS is expected to result from the same or similar pathways as described for ZS patients. Additionally, we determined the absolute configuration of urinary 3-hydroxysebacic acid (3-HS) in the cases investigated. The enantioselective analysis provides further information for the diagnosis and treatment of patients with impaired peroxisomal fatty acid oxidation. Further insight into the metabolic origin and the biochemical pathway leading to these urinary metabolites is provided.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE